ANIX insider transaction filings
Anixa Biosciences Inc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-14. Screen ANIX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 12 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 11 filings by 2 insiders — 58,985 shares, $189,148 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 12,000 shares @ $3.47 ($41,640) by Titterton Lewis H jr, filed 2026-07-20.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| KUMAR AMIT — Chief Executive Officer, Director | 8 | 8 legs · 34,188 sh · $111,034 | — | — |
| Titterton Lewis H jr — Director | 3 | 3 legs · 24,797 sh · $78,114 | — | — |
| Baskies Arnold M — Director | 1 | — | — | 3 |
Recent Form 4 filings — Anixa Biosciences Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 3,000 @ $2.75 | EDGAR |
| 2026-09-14 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $2.73 | EDGAR |
| 2026-09-11 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $2.76 | EDGAR |
| 2026-08-03 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.47 | EDGAR |
| 2026-07-29 | 4 | Baskies Arnold M — Director | Option exercise (M): 6,000 @ $3.13 · Tax withholding (F): 5,428 @ $3.46 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.44 | EDGAR |
| 2026-07-27 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 3,188 @ $3.37 | EDGAR |
| 2026-07-27 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 3,000 @ $3.73 | EDGAR |
| 2026-07-21 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.46 | EDGAR |
| 2026-07-20 | 4 | Titterton Lewis H jr — Director | Purchase (P): 12,000 @ $3.47 | EDGAR |
| 2026-07-16 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,797 @ $3.28 | EDGAR |
| 2026-07-13 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 5,000 @ $3.04 | EDGAR |
| 2026-06-17 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,836 @ $2.64 | EDGAR |
| 2026-06-16 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Purchase (P): 21,000 @ $2.50 | EDGAR |
| 2026-01-29 | 4 | Baskies Arnold M — Director | Purchase (P): 10,000 @ $3.04 | EDGAR |
| 2026-01-06 | 4 | Gottschalk Emily — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Catelani Michael — President, COO & CFO | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Baskies Arnold M — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Titterton Lewis H jr — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Titterton Lewis H jr — Director | Option exercise (M): 16,000 @ $2.92 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | KUMAR AMIT — Chief Executive Officer | Option exercise (M): 200,000 @ $2.92 · Tax withholding (F): 169,439 @ $4.06 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $3.08 | EDGAR |
| 2025-07-31 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 5,000 @ $3.16 | EDGAR |
| 2025-07-21 | 4 | Baskies Arnold M — Director | Purchase (P): 5,000 @ $3.39 | EDGAR |
| 2025-07-15 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $3.14 | EDGAR |
| 2025-07-14 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 5,000 @ $3.15 | EDGAR |
| 2025-06-05 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 10,000 @ $2.85 | EDGAR |
| 2025-01-29 | 4 | Baskies Arnold M — Director | Purchase (P): 5,000 @ $2.82 | EDGAR |
| 2025-01-27 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,000 @ $2.91 · Purchase (P): 1,000 @ $3 | EDGAR |
| 2025-01-23 | 4 | Titterton Lewis H jr — Director | Purchase (P): 2,000 @ $3.01 | EDGAR |
| 2025-01-22 | 4 | Titterton Lewis H jr — Director | Purchase (P): 6,000 @ $2.59 | EDGAR |
| 2025-01-17 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,000 @ $2.57 | EDGAR |
| 2025-01-15 | 4 | Catelani Michael — President, COO, & CFO | Purchase (P): 9,289 @ $2.15 | EDGAR |
| 2025-01-15 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 43,000 @ $2.23 | EDGAR |
| 2025-01-03 | 4 | Gottschalk Emily — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Catelani Michael — President, COO & CFO | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Baskies Arnold M — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Titterton Lewis H jr — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | KUMAR AMIT — Chief Executive Officer, Director | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Titterton Lewis H jr — Director | Option exercise (M): 16,000 @ $2.58 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Titterton Lewis H jr — Director | Purchase (P): 21,646 @ $3.06 · Purchase (P): 5,580 @ $3.23 | EDGAR |
| 2024-07-29 | 4 | Titterton Lewis H jr — Director | Purchase (P): 796 @ $2.81 · Purchase (P): 7,700 @ $3.03 | EDGAR |
| 2024-07-26 | 4 | Baskies Arnold M — Director | Purchase (P): 5,000 @ $3.09 | EDGAR |
| 2024-06-18 | 4 | Titterton Lewis H jr — Director | Purchase (P): 4,000 @ $2.68 | EDGAR |
| 2024-06-14 | 4 | Titterton Lewis H jr — Director | Purchase (P): 405 @ $2.70 | EDGAR |
| 2024-06-12 | 4 | Titterton Lewis H jr — Director | Purchase (P): 330 @ $2.60 · Purchase (P): 7,102 @ $2.66 | EDGAR |
| 2024-06-10 | 4 | Titterton Lewis H jr — Director | Purchase (P): 10,738 @ $2.52 | EDGAR |
| 2024-06-07 | 4 | Catelani Michael — President, COO, & CFO | Purchase (P): 6,250 @ $2.40 | EDGAR |
| 2024-06-07 | 4 | KUMAR AMIT — Chief Executive Officer | Purchase (P): 25,000 @ $2.41 | EDGAR |
Recent 8-K events — Anixa Biosciences Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-03-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →